METHODS	Men or women 18 years of age , with dyslipidemia ( non-high-density lipoprotein cholesterol 100 mg/dL and 220 mg/dL ; high-density lipoprotein cholesterol < 60 mg/dL ) and fasting plasma glucose ( FPG ) 90 mg/dL and 145 mg/dL were randomly assigned 1:1 to colesevelam ( 3750 mg/d ) with niacin titration ( n = 70 ) or placebo with niacin titration ( n = 70 ) over 12 weeks .\